LGM

Logos Global Management Portfolio holdings

AUM $749M
1-Year Return 18.94%
This Quarter Return
-10.82%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$1.02B
AUM Growth
-$125M
Cap. Flow
+$84.4M
Cap. Flow %
8.23%
Top 10 Hldgs %
68.99%
Holding
83
New
24
Increased
8
Reduced
9
Closed
29

Top Buys

1
DSGN icon
Design Therapeutics
DSGN
$81.7M
2
TIL icon
Instil Bio
TIL
$46.3M
3
EWTX icon
Edgewise Therapeutics
EWTX
$34.3M
4
DYN icon
Dyne Therapeutics
DYN
$24.8M
5
BCYC
Bicycle Therapeutics
BCYC
$23.9M

Top Sells

1
TGTX icon
TG Therapeutics
TGTX
$44.2M
2
KROS icon
Keros Therapeutics
KROS
$31.7M
3
APLS icon
Apellis Pharmaceuticals
APLS
$17.2M
4
RNA icon
Avidity Biosciences
RNA
$17.1M
5
NKTX icon
Nkarta
NKTX
$13.9M

Sector Composition

1 Healthcare 99.46%
2 Financials 0.5%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ISEE
26
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$7.42M 0.72%
+1,200,000
New +$7.42M
KNSA icon
27
Kiniksa Pharmaceuticals
KNSA
$2.63B
$7.4M 0.72%
+400,000
New +$7.4M
LABP
28
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$7.07M 0.69%
+73,400
New +$7.07M
PMVP icon
29
PMV Pharmaceuticals
PMVP
$76.3M
$6.58M 0.64%
200,000
+100,000
+100% +$3.29M
HARP
30
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$6.28M 0.61%
+30,000
New +$6.28M
SPRY icon
31
ARS Pharmaceuticals
SPRY
$1.06B
$5.45M 0.53%
125,000
-175,000
-58% -$7.64M
PNT
32
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$5.26M 0.51%
500,000
– –
BOLT icon
33
Bolt Biotherapeutics
BOLT
$9.29M
$4.94M 0.48%
+7,500
New +$4.94M
KZR icon
34
Kezar Life Sciences
KZR
$28M
$4.77M 0.47%
+80,000
New +$4.77M
ANNX icon
35
Annexon
ANNX
$236M
$4.44M 0.43%
159,622
– –
VIRX
36
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.35M 0.42%
+470,000
New +$4.35M
CCCC icon
37
C4 Therapeutics
CCCC
$190M
$4.18M 0.41%
112,928
-365,000
-76% -$13.5M
LRMR icon
38
Larimar Therapeutics
LRMR
$331M
$3.36M 0.33%
230,000
-485,000
-68% -$7.09M
OBIO icon
39
Orchestra BioMed
OBIO
$148M
$3.36M 0.33%
300,000
– –
HRMY icon
40
Harmony Biosciences
HRMY
$2.09B
$3.3M 0.32%
100,000
– –
RACB
41
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$3.08M 0.3%
+300,000
New +$3.08M
LHDX
42
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$3.03M 0.3%
+250,000
New +$3.03M
PRDS
43
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$2.99M 0.29%
+300,000
New +$2.99M
DCPH
44
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.78M 0.27%
+62,000
New +$2.78M
CNTB
45
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$99.2M
$2.78M 0.27%
+150,000
New +$2.78M
EAR
46
DELISTED
Eargo, Inc. Common Stock
EAR
$2.5M 0.24%
2,500
– –
ELDN icon
47
Eledon Pharmaceuticals
ELDN
$156M
$2.4M 0.23%
224,071
– –
TNGX icon
48
Tango Therapeutics
TNGX
$760M
$2.22M 0.22%
200,000
– –
PASG icon
49
Passage Bio
PASG
$22.3M
$2.19M 0.21%
6,251
-10,971
-64% -$3.83M
ARYD
50
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.1M 0.2%
+200,000
New +$2.1M
1
2
3 4